Genomics Plc

Oxford, GB · 1 known investors

Genomics uses polygenic risk scores and DNA analysis to predict an individual's risk of common diseases, serving healthcare providers, employers, insurers, and pharmaceutical companies. Founded from University of Oxford research, its platform supports disease risk prediction, drug discovery, and clinical trial design.